Involvement of Crk Adapter Proteins in Regulation of Lymphoid Cell Functions

Immunologic Research

Volumn 28, Issue 2, 2003, Pages 79-91

  Gelkop, Sigal ^a   Babichev, Yael ^a   Kalifa, Rachel ^a   Tamir, Ami ^a   Isakov, Noah ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Adapter protein; Cbl; Crk; Lymphocyte activation; Signal transduction; Src homology 2; ZAP 70

Indexed keywords

ADAPTOR PROTEIN; BCR ABL PROTEIN; DOCKING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HEMATOPOIETIC PROGENITOR KINASE 1; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN CRK; PROTEIN P85; PROTEIN P97; SOS PROTEIN; STAT5 PROTEIN; UNCLASSIFIED DRUG;

CELL FUNCTION; HUMAN; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOID CELL; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; HUMANS; LYMPHOCYTES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-CRK; SRC HOMOLOGY DOMAINS;

EID: 0345257729     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:28:2:79     Document Type: Review

References (89)

1. Mayer BJ, Hamaguchi M, Hanafusa H: A novel viral oncogene with structural similarity to phospholipase C. Nature 1988;332:272-275.
2. Matsuda M, Tanaka S, Nagata S, Kojima A, Kurata T, Shibuya M: Two species of human CRK cDNA encode proteins with distinct biological activities. Mol Cell Biol 1992;12:3482-3489.
3. Reichman CT, Mayer BJ, Keshav S, Hanafusa H: The product of the cellular crk gene consists primarily of SH2 and SH3 regions. Cell Growth Differ 1992;3:451-460.
4. Fioretos T, Heisterkamp N, Groffen J, Benjes S, Morris C: CRK proto-oncogene maps to human chromosome band 17p13. Oncogene 1993;8:2853-2855.
5. Ogawa S, Toyoshima H, Kozutsumi H, Hagiwara K, Sakai R, Tanaka T, Hirano N, Mano H, Yazaki Y, Hirai H: The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells. Oncogene 1994;9: 1669-1678.
6. ten Hoeve J, Morris C, Heisterkamp N, Groffen J: Isolation and chromosomal localization of CRKL, a human crk-like gene. Oncogene 1993;8:2469-2474.
7. de Jong R, Haataja L, Voncken JW, Heisterkamp N, Groffen J: Tyrosine phosphorylation of murine CrkL. Oncogene 1995;11:1469-1474.
8. Feller SM, Ren R, Hanafusa H, Baltimore D: SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl. Trends Biochem Sec 1994;19:453-458.
9. Birge RB, Knudsen BS, Besser D, Hanafusa H: SH2 and SH3-containing adaptor proteins: redundant or independent mediators of intracellular signal transduction. Genes Cells 1996;1:595-613.
10. Kiyokawa E, Mochizuki N, Kurata T, Matsuda M: Role of Crk oncogene product in physiologic signaling. Crit Rev Oncog 1997;8:329-342.
11. Sattler M, Salgia R: Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells. Leukemia 1998;12:637-644.
12. Kolibaba KS, Bhat A, Heaney C, Oda T, Druker BJ: CRKL binding to BCR-ABL and BCR-ABL transformation. Leuk Lymphoma 1999;33:119-126.
13. Feller SM: Crk family adaptors-signalling complex formation and biological roles. Oncogene 2001;20: 6348-6371.
14. Songyang Z, Shoelson SE, Chaudhuri M, et al.: SH2 domains recognize specific phosphopeptide sequences. Cell 1993;72:767-778.
15. Gelkop S, Babichev Y, Isakov N: T cell activation induces direct binding of the Crk adapter protein to the regulatory subunit of phosphatidylinositol 3-kinase (p85) via a complex mechanism involving the Cbl protein. J Biol Chem 2001;276:36,174-36,182.
16. Gelkop S, Isakov N: T cell activation stimulates the association of enzymatically active tyrosine-phosphorylated ZAP-70 with the Crk adapter proteins. J Biol Chem 1999;274:21,519-21,527.
17. Knudsen BS, Feller SM, Hanafusa H: Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of Crk. J Biol Chem 1994;269: 32,781-32,787.
18. Tanaka S, Morishita T, Hashimoto Y, Hattori S, Nakamura S, Shibuya M, Matuoka K, Takenawa T, Kurata T, Nagashima K, Matsuda M: C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc Natl Acad Sci USA 1994;91:3443-3447.
19. Knudsen BS, Zheng J, Feller SM, Mayer JP, Burrell SK, Cowburn D, Hanafusa H: Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteins. EMBO J 1995;14:2191-2198.
20. Wu X, Knudsen B, Feller SM, Zheng J, Sali A, Cowburn D, Hanafusa H, Kuriyan J: Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure 1995;3:215-226.
21. Smith JJ, Richardson DA, Kopf J, Yoshida M, Hollingsworth RE, Kornbluth S: Apoptotic regulation by the Crk adapter protein mediated by interactions with Wee1 and Crm1/exportin. Mol Cell Biol 2002;22: 1412-1423.
22. Feller SM, Knudsen B, Hanafusa H: c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J 1994;13:2341-2351.
23. de Jong R, ten Hoeve J, Heisterkamp N, Groffen J: Tyrosine 207 in CRKL is the BCR/ABL phosphorylation site. Oncogene 1997;14:507-513.
24. Rosen MK, Yamazaki T, Gish GD, Kay CM, Pawson T, Kay LE: Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein. Nature 1995;374:477-479.
25. Anafi M, Rosen MK, Gish GD, Kay LE, Pawson T: A potential SH3 domain-binding site in the Crk SH2 domain. J Biol Chem 1996;271:21,365-21,374.
26. Matsuda M, Hashimoto Y, Muroya K, Hasegawa H, Kurata T, Tanaka S, Nakamura S, Hattori S: CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells. Mol Cell Biol 1994;14:5495-5500.
27. Sawasdikosol S, Ravichandran KS, Lee KK, Chang JH, Burakoff SJ: Crk interacts with tyrosine-phosphorylated p116 upon T cell activation. J Biol Chem 1995;270: 2893-2896.
28. Smit L, van der Horst G, Borst J: Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors. J Biol Chem 1996;271:8564-8569.
29. Zwartkruis FJ, Bos JL: Ras and Rap1: two highly related small GTPases with distinct function. Exp Cell Res 1999;253:157-165.
30. Boussiotis VA, Freeman GJ, Berezovskaya A, Barber DL, Nadler LM: Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science 1997;278:124-128.
31. Amsen D, Kruisbeek A, Bos JL, Reedquist K: Activation of the Ras-related GTPase Rap1 by thymocyte TCR engagement and during selection. Eur J Immunol 2000;30:2832-2841.
32. Ishimaru S, Williams R, Clark E, Hanafusa H, Gaul U: Activation of the Drosophila C3G leads to cell fate changes and overproliferation during development, mediated by the RAS-MAPK pathway and RAP1. EMBO J 1999;18:145-155.
33. Zwartkruis FJ, Wolthuis RM, Nabben NM, Franke B, Bos JL: Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling. EMBO J 1998;17:5905-5912.
34. ten Hoeve J, Kaartinen V, Fioretos T, Haataja L, Voncken JW, Heisterkamp N, Groffen J: Cellular interactions of CRKL, and SH2-SH3 adaptor protein. Cancer Res 1994;54:2563-2567.
35. Reedquist KA, Fukazawa T, Panchamoorthy G, Langdon WY, Shoelson SE, Druker BJ, Band H: Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G. J Biol Chem 1996:271:8435-8442.
36. Arai A, Nosaka Y, Kohsaka H, Miyasaka N, Miura O: CrkL activates integrin-mediated hematopoietic cell adhesion through the guanine nucleotide exchange factor C3G. Blood 1999;93:3713-3722.
37. Uemura N, Salgia R, Ewaniuk DS, Little MT, Griffin JD: Involvement of the adapter protein CRKL in integrin-mediated adhesion. Oncogene 1999;18:3343-3353.
38. Smith JM, Mayer BJ: Abl: mechanisms of regulation and activation. Front Biosci 2002;7:d31-d42.
39. ODwyer ME, Druker BJ: The role of the tyrosine kinase inhibitor STI571 in the treatment of cancer. Curr Cancer Drug Targets 2001;1:49-57.
40. Shishido T, Akagi T, Chalmers A, Maeda M, Terada T, Georgescu MM, Hanafusa H: Crk family adaptor proteins trans-activate c-Abl kinase. Genes Cells 2001; 6:431-440.
41. Ling P, Yao Z, Meyer CF, Wang XS, Oehrl W, Feller SM, Tan TH: Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinase. Mol Cell Biol 1999;19:1359-1368.
42. Ling P, Meyer CF, Redmond LP, Shui JW, Davis B, Rich RR, Hu MC, Wange RL, Tan TH: Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling. J Biol Chem 2001;276:18,908-18,914.
43. Gesbert F, Garbay C, Bertoglio J: Interleukin-2 stimulation induces tyrosine phosphorylation of p120-Cbl and CrkL and formation of multimolecular signaling complexes in T lymphocytes and natural killer cells. J Biol Chem 1998;273:3986-3993.
44. Fukazawa T, Miyake S, Band V, Band H: Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins. J Biol Chem 1996;271: 14,554-14,559.
45. Husson H, Mograbi B, Schmid-Antomarchi H, Fischer S, Rossi B: CSF-1 stimulation induces the formation of a multiprotein complex including CSF-1 receptor, c-Cbl, PI 3-kinase, Crk-II and Grb2. Oncogene 1997;14: 2331-2338.
46. Cbl. J Biol Chem 1997;272:10,248-10,253.
47. Chan AC, Irving BA, Fraser JD, Weiss A: The zeta chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein. Proc Natl Acad Sci USA 1991;88:9166-9170.
48. Katzav S, Sutherland M, Packham G, Yi T, Weiss A: The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav. J Biol Chem 1994;269: 32,579-33,285.
49. + thymic selection in humans lacking ZAP-70 kinase. Cell 1994;76:947-958.
50. Chan AC, Kadlecek TA, Elder ME, Filipovich AH, Kuo WL, Iwashima M, Parslow TG, Weiss A: ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 1994;264:1599-1601.
51. Elder ME, Lin D, Clever J, Chan AC, Hope TJ, Weiss A, Parslow TG: Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science 1994;264:1596-1599.
52. Xavier R, Brennan T, Li Q, McCormack C, Seed B: Membrane compartmentation is required for efficient T cell activation. Immunity 1998;8:723-732.
53. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML: The immunological synapse: a molecular machine controlling T cell activation. Science 1999;285:221-227.
54. Huby RDJ, Iwashima M, Weiss A, Ley SC: ZAP-70 protein tyrosine kinase is constitutively targeted to the T cell cortex independently of its SH2 domains. J Cell Biol 1997;137:1639-1649.
55. Mayer BJ, Hirai H, Sakai R: Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases. Curr Biol 1995;5:296-305.
56. Songyang Z, Carraway KLI, Eck MJ, et al.: Catalytic specificity of protein-tyrosine kinases is critical for selective signaling. Nature 1995;373:536-539.
57. Isakov N, Wange RL, Watts JD, Aebersold R, Samelson LE: Purification and characterization of human ZAP-70 proteins tyrosine kinase from a baculovirus expression system. J Biol Chem 1996;271:15,753-15,761.
58. Thien CB, Langdon WY: Cbl: many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol 2001;2:294-307.
59. Liu YC, Gu H: Cbl and Cbl-b in T-cell regulation. Trends Immunol 2002;23:140-143.
60. Rellahan BL, Graham LJ, Stoica B, De-Bell KE, Bonvini E: Cbl-mediated regulation of T cell receptor-induced AP1 activation: implications for activation via the Ras signaling pathway. J Biol Chem 1997;272: 30,806-30,811.
61. Ota S, Hazeki K, Rao N, Lupher ML Jr, Andoniou CE, Druker B, Band H: The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase. J Biol Chem 2000;275:414-422.
62. Ota Y, Samelson LE: The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase. Science 1997;276:418-420.
63. Lupher ML Jr, Rao N, Eck MJ, Band H: The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction. Immunol Today 1999;20:375-382.
64. Murphy MA, Schnall RG, Venter DJ, Barnett L, Bertoncello I, Thien CB, Langdon WY, Bowtell DD: Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol Cell Biol 1998;18: 4872-4882.
65. van Leeuwen JE, Paik PK, Samelson LE: Activation of nuclear factor of activated T cells-(NFAT) and activating protein 1 (AP-1) by oncogenic 70Z Cbl requires an intact phosphotyrosine binding domain but not Crk(L) or p85 phosphatidylinositol 3-kinase association. J Biol Chem 1999;274:5153-5162.
66. Zhang Z, Elly C, Altman A, Liu YC: Dual regulation of T cell receptor-mediated signaling by oncogenic Cbl mutant 70Z. J Biol Chem 1999;274:4883-4889.
67. Elly C, Witte S, Zhang Z, Rosnet O, Lipkowitz S, Altman A, Liu YC: Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation. Oncogene 1999;18:1147-1156.
68. Andoniou CE, Thien CB, Langdon WY: The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain. Oncogene 1996;12: 1981-1989.
69. 2+-stimulated activation of nuclear factor of activated T cells by a constitutively active Cbl mutant in T cells. J Biol Chem 1997;272:168-173.
70. Hunter S, Burton EA, Wu SC, Anderson SM: Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase. J Biol Chem 1999;274:2097-2106.
71. Booker GW, Gout I, Downing AK, Driscoll PC, Boyd J, Waterfield MD, Campbell ID: Solution structure and ligand-binding site of the SH3 domain of the p85α subunit of phosphatidylinositol 3-kinase. Cell 1993;73: 813-822.
72. Sparks AB, Rider JE, Hoffman NG, Fowlkes DM, Quillam LA, Kay BK: Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2. Proc Natl Acad Sci USA 1996;93:1540-1544.
73. Matsuda M, Ota S, Tanimura R, Nakamura H, Matuoka K, Takenawa T, Nagashima K, Kurata T: Interaction between the amino-terminal SH3 domain of CRK and its natural target proteins. J Biol Chem 1996;271: 14,468-14,472.
74. Hartley D, Meisner H, Corvera S: Specific association of the beta isoform of the p85 subunit of phosphatidylinositol-3 kinase with the proto-oncogene c-cbl. J Biol Chem 1995;270:18,260-18,263.
75. Brenner B, Kadel S, Birle A, Linderkamp O: L-selectin tyrosine phosphorylates Cbl and induces association of tyrosine-phosphorylated Cbl with CrkL and Grb2. Biochem Biophys Res Commun 2001;282:41-47.
76. Chernock RD, Cherla RP, Ganju RK: SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways. Blood 2001;97:608-615.
77. Uemura N, Griffin JD: The adapter protein CrkL links Cbl to C3G after integrin ligation and enhances cell migration. J Biol Chem 1999;274:37,525-37, 532.
78. Minegishi M, Tachibana K, Sato T, Iwata S, Nojima Y, Morimoto C: Structure and function of Cas-L, a 105-kD Crk-associated substrate-related protein that is involved in beta 1 integrin-mediated signaling in lymphocytes. J Exp Med 1996;184:1365-1375.
79. Kanda H, Mimura T, Morino N, Hamasaki K, Nakamoto T, Hirai H, Morimoto C, Yazaki Y, Nojima Y: Ligation of the T cell antigen receptor induces tyrosine phosphorylation of p105CasL, a member of the p130Cas-related docking protein family, and its subsequent binding to the Src homology 2 domain of c-Crk. Eur J Immunol 1997;27:2113-2117.
80. Ohashi Y, Tachibana K, Kamiguchi K, Fujita H, Morimoto C: T cell receptor-mediated tyrosine phosphorylation of Cas-L, a 105-kDa Crk-associated substrate-related protein, and its association of Crk and C3G. J Biol Chem 1998;273:6446-6451.
81. Iwata S, Ohashi Y, Kamiguchi K, Morimoto C: Beta 1-integrin-mediated cell signaling in T lymphocytes. J Dermatol Sci 2000;23:75-86.
82. HEF1, a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells. J Biol Chem 1997;272:4230-4236.
83. cas and its association with c-CrkII. J Biol Chem 1996;271:7796-7801.
84. Sugie K, Minami Y, Kawakami T, Uchida A: Stimulation of NK-like YT cells via leukocyte function-associated antigen (LFA)-1. Possible involvement of LFA-1-associated tyrosine kinase in signal transduction after recognition of NK target cells. J Immunol 1995;154: 1691-1698.
85. Gesbert F, Guenzi C, Bertoglio J: A new tyrosine-phosphorylated 97-kDa adaptor protein mediates interleukin-2-induced association of SHP-2 with p85-phosphatidylinositol 3-kinase in human T lymphocytes. J Biol Chem 1998;273:18,273-18,281.
86. Carlberg K, Rohrschneider LR: Characterization of a novel tyrosine phosphorylated 100-kDa protein that binds to SHP-2 and phosphatidylinositol 3′-kinase in myeloid cells. J Biol Chem 1997;272:15,943-15,950.
87. Gu H, Griffin JD, Neel BG: Characterization of two SHP-2-associated binding proteins and potential substrates in hematopoietic cells. J Biol Chem 1997;272: 16,421-16,430.
88. Craddock BL, Welham MJ: Interleukin-3 induces association of the protein-tyrosine phosphatase SHP2 and phosphatidylinositol 3-kinase with a 100-kDa tyrosine-phosphorylated protein inhemopoietic cells. J Biol Chem 1997;272:29,281-29,289.
89. Evans EK, Lu W, Strum SL, Mayer BJ, Kornbluth S: Crk is required for apoptosis in Xenopus egg extracts. EMBO J 1997;16:230-241.